Comprehensive Assessment of Multiple Products (CAMP)

April 9, 2026 updated by: CooperVision International Limited (CVIL)
The aim of this study is to assess contact lens performance and acceptance.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The objective of this study is to assess the initial performance and acceptance of a range of contact lenses in habitual soft contact lens wearers.

Study Type

Interventional

Enrollment (Actual)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Indiana
      • Bloomington, Indiana, United States, 47405
        • Indiana University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Age 18 to 45 years (inclusive)
  2. Habitual soft spherical contact lens wearer (current prescription)
  3. Refractive error of -6.00 to -0.50DS or +0.50 to +6.00DS and less than or equal to 0.75DC as vertexed to the corneal plane
  4. Anisometropia no greater than 1.50D, based on vertexed manifest refraction spherical equivalent
  5. Can achieve visual acuity of at least 20/25 in each eye with spherical equivalent manifest refraction

Exclusion Criteria:

  1. Active anterior segment infection, inflammation or abnormality that would contraindicate contact lens wear
  2. Use of systemic or ocular medication that would contraindicate contact lens wear
  3. Used gas permeable/hard contact lenses (including orthokeratology) in the previous 3 months
  4. Participation in a contact lens or lens care product trial in the previous 30 days

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: somofilcon A lens
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
Device: somofilcon A lens
Participants will be randomized to wear somofilcon A soft contact lens for 10 hours.
Experimental: stenfilcon A lens
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
Device: stenfilcon A lens
Participants will be randomized to wear stenfilcon A soft contact lens for 10 hours.
Experimental: fanfilcon A lens
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
Device: fanfilcon A lens
Participants will be randomized to wear fanfilcon A soft contact lens for 10 hours.
Experimental: comfilcon A lens
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
Device: comfilcon A lens
Participants will be randomized to wear comfilcon A soft contact lens for 10 hours.
Experimental: verofilcon A lens
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
Device: verofilcon A lens
Participants will be randomized to wear verofilcon A soft contact lens for 10 hours.
Experimental: serafilcon A lens
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
Device: serafilcon A lens
Participants will be randomized to wear serafilcon A soft contact lens for 10 hours.
Experimental: lehfilcon A lens
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
Device: lehfilcon A lens
Participants will be randomized to wear lehfilcon A soft contact lens for 10 hours.
Experimental: delefilcon A lens
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
Device: delefilcon A lens
Participants will be randomized to wear delefilcon A soft contact lens for 10 hours.
Experimental: senofilcon A lens daily disposable
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
Device: senofilcon A daily disposable lens
Participants will be randomized to wear senofilcon A soft contact lens for 10 hours.
Experimental: senofilcon A lens with blue light technology
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
Device: senofilcon A with blue light technology lens
Participants will be randomized to wear senofilcon A soft contact lens for 10 hours.
Experimental: senofilcon A lens bi-weekly replacement
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
Device: senofilcon A bi-weekly lens
Participants will be randomized to wear senofilcon A soft contact lens for 10 hours.
Experimental: samfilcon A lens
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
Device: samfilcon A lens
Participants will be randomized to wear samfilcon A soft contact lens for 10 hours.
Experimental: kalifilcon A lens
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
Device: kalilfilcon A lens
Participants will be randomized to wear kalifilcon A soft contact lens for 10 hours.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
High contrast, high luminance binocular distance visual acuity
Time Frame: At the end of 10 hours of daily wear at dispensing
High contrast, high luminance binocular distance visual acuity (logMAR) will be measured at 10-hour visit.
At the end of 10 hours of daily wear at dispensing

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

CooperVision International Limited (CVIL)

Investigators

  • Principal Investigator: Pete Kollbaum, OD, PhD, Indiana University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 12, 2025

Primary Completion (Actual)

December 17, 2025

Study Completion (Actual)

December 17, 2025

Study Registration Dates

First Submitted

December 1, 2025

First Submitted That Met QC Criteria

December 1, 2025

First Posted (Actual)

December 11, 2025

Study Record Updates

Last Update Posted (Actual)

April 13, 2026

Last Update Submitted That Met QC Criteria

April 9, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • EX-MKTG-167

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myopia

Clinical Trials on somofilcon A lens

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe